Literature DB >> 21592478

Meta analysis of candidate gene variants outside the LPA locus with Lp(a) plasma levels in 14,500 participants of six White European cohorts.

Delilah Zabaneh1, Meena Kumari, Manj Sandhu, Nick Wareham, Nick Wainwright, Theodore Papamarkou, Jemma Hopewell, Robert Clarke, KaWah Li, Jutta Palmen, Philippa J Talmud, Florian Kronenberg, Claudia Lamina, Monika Summerer, Bernhard Paulweber, Jackie Price, Gerry Fowkes, Marlene Stewart, Fotios Drenos, Sonia Shah, Tina Shah, Juan-Pablo Casas, Mika Kivimaki, John Whittaker, Aroon D Hingorani, Steve E Humphries.   

Abstract

BACKGROUND: Both genome-wide association studies and candidate gene studies have reported that the major determinant of plasma levels of the Lipoprotein (a) [Lp(a)] reside within the LPA locus on chromosome 6. We have used data from the HumanCVD BeadChip to explore the contribution of other candidate genes determining Lp(a) levels.
METHODS: 48,032 single nucleotide polymorphisms (SNPs) from the Illumina HumanCVD BeadChip were genotyped in 5059 participants of the Whitehall II study (WHII) of randomly ascertained healthy men and women. SNPs showing association with Lp(a) levels of p<10(-4) outside the LPA locus were selected for replication in a total of an additional 9463 participants of five European based studies (EAS, EPIC-Norfolk, NPHSII, PROCARDIS, and SAPHIR).
RESULTS: In Whitehall II, apart from the LPA locus (where p values for several SNPs were <10(-30)) there was significant association at four loci GALNT2, FABP1, PPARGC1A and TNFRSFF11A. However, a meta-analysis of the six studies did not confirm any of these findings.
CONCLUSION: Results from this meta analysis of 14,522 participants revealed no candidate genes from the HumanCVD BeadChip outside the LPA locus to have an effect on Lp(a) levels. Further studies with genome-wide and denser SNP coverage are required to confirm or refute this finding.
Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21592478      PMCID: PMC3972487          DOI: 10.1016/j.atherosclerosis.2011.04.015

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  29 in total

1.  A new multipoint method for genome-wide association studies by imputation of genotypes.

Authors:  Jonathan Marchini; Bryan Howie; Simon Myers; Gil McVean; Peter Donnelly
Journal:  Nat Genet       Date:  2007-06-17       Impact factor: 38.330

2.  A simple salting out procedure for extracting DNA from human nucleated cells.

Authors:  S A Miller; D D Dykes; H F Polesky
Journal:  Nucleic Acids Res       Date:  1988-02-11       Impact factor: 16.971

3.  cDNA sequence of human apolipoprotein(a) is homologous to plasminogen.

Authors:  J W McLean; J E Tomlinson; W J Kuang; D L Eaton; E Y Chen; G M Fless; A M Scanu; R M Lawn
Journal:  Nature       Date:  1987 Nov 12-18       Impact factor: 49.962

4.  Comprehensive analysis of genomic variation in the LPA locus and its relationship to plasma lipoprotein(a) in South Asians, Chinese, and European Caucasians.

Authors:  Matthew B Lanktree; Sonia S Anand; Salim Yusuf; Robert A Hegele
Journal:  Circ Cardiovasc Genet       Date:  2009-12-30

5.  Effect of sample storage on the measurement of lipoprotein[a], apolipoproteins B and A-IV, total and high density lipoprotein cholesterol and triglycerides.

Authors:  F Kronenberg; E M Lobentanz; P König; G Utermann; H Dieplinger
Journal:  J Lipid Res       Date:  1994-07       Impact factor: 5.922

6.  Apolipoprotein(a) gene accounts for greater than 90% of the variation in plasma lipoprotein(a) concentrations.

Authors:  E Boerwinkle; C C Leffert; J Lin; C Lackner; G Chiesa; H H Hobbs
Journal:  J Clin Invest       Date:  1992-07       Impact factor: 14.808

7.  Edinburgh Artery Study: prevalence of asymptomatic and symptomatic peripheral arterial disease in the general population.

Authors:  F G Fowkes; E Housley; E H Cawood; C C Macintyre; C V Ruckley; R J Prescott
Journal:  Int J Epidemiol       Date:  1991-06       Impact factor: 7.196

8.  Osteoclast formation, survival and morphology are highly dependent on exogenous cholesterol/lipoproteins.

Authors:  E Luegmayr; H Glantschnig; G A Wesolowski; M A Gentile; J E Fisher; G A Rodan; A A Reszka
Journal:  Cell Death Differ       Date:  2004-07       Impact factor: 15.828

9.  Genetic evidence for a role of adiponutrin in the metabolism of apolipoprotein B-containing lipoproteins.

Authors:  Barbara Kollerits; Stefan Coassin; Noam D Beckmann; Alexander Teumer; Stefan Kiechl; Angela Döring; Maryam Kavousi; Steven C Hunt; Claudia Lamina; Bernhard Paulweber; Zoltán Kutalik; Matthias Nauck; Cornelia M van Duijn; Iris M Heid; Johann Willeit; Anita Brandstätter; Ted D Adams; Vincent Mooser; Yurii S Aulchenko; Henry Völzke; Florian Kronenberg
Journal:  Hum Mol Genet       Date:  2009-09-03       Impact factor: 6.150

10.  Genetic variants associated with Lp(a) lipoprotein level and coronary disease.

Authors:  Robert Clarke; John F Peden; Jemma C Hopewell; Theodosios Kyriakou; Anuj Goel; Simon C Heath; Sarah Parish; Simona Barlera; Maria Grazia Franzosi; Stephan Rust; Derrick Bennett; Angela Silveira; Anders Malarstig; Fiona R Green; Mark Lathrop; Bruna Gigante; Karin Leander; Ulf de Faire; Udo Seedorf; Anders Hamsten; Rory Collins; Hugh Watkins; Martin Farrall
Journal:  N Engl J Med       Date:  2009-12-24       Impact factor: 91.245

View more
  11 in total

Review 1.  Lipoprotein (a) as a cause of cardiovascular disease: insights from epidemiology, genetics, and biology.

Authors:  Børge G Nordestgaard; Anne Langsted
Journal:  J Lipid Res       Date:  2016-09-27       Impact factor: 5.922

2.  Evidence for several independent genetic variants affecting lipoprotein (a) cholesterol levels.

Authors:  Wensheng Lu; Yu-Ching Cheng; Keping Chen; Hong Wang; Glenn S Gerhard; Christopher D Still; Xin Chu; Rongze Yang; Ankita Parihar; Jeffrey R O'Connell; Toni I Pollin; Eduardo Angles-Cano; Michael J Quon; Braxton D Mitchell; Alan R Shuldiner; Mao Fu
Journal:  Hum Mol Genet       Date:  2015-01-09       Impact factor: 6.150

Review 3.  Lipoprotein (a): impact by ethnicity and environmental and medical conditions.

Authors:  Byambaa Enkhmaa; Erdembileg Anuurad; Lars Berglund
Journal:  J Lipid Res       Date:  2015-12-04       Impact factor: 5.922

4.  Effect of antiretroviral therapy on allele-associated Lp(a) level in women with HIV in the Women's Interagency HIV Study.

Authors:  Byambaa Enkhmaa; Erdembileg Anuurad; Wei Zhang; Chin-Shang Li; Robert Kaplan; Jason Lazar; Dan Merenstein; Roksana Karim; Brad Aouizerat; Mardge Cohen; Kenneth Butler; Savita Pahwa; Igho Ofotokun; Adaora A Adimora; Elizabeth Golub; Lars Berglund
Journal:  J Lipid Res       Date:  2018-07-16       Impact factor: 5.922

5.  Association of the GALNT2 gene polymorphisms and several environmental factors with serum lipid levels in the Mulao and Han populations.

Authors:  Qing Li; Rui-Xing Yin; Ting-Ting Yan; Lin Miao; Xiao-Li Cao; Xi-Jiang Hu; Lynn Htet Htet Aung; Dong-Feng Wu; Jin-Zhen Wu; Wei-Xiong Lin
Journal:  Lipids Health Dis       Date:  2011-09-20       Impact factor: 3.876

6.  Genome-wide association study of genetic determinants of LDL-c response to atorvastatin therapy: importance of Lp(a).

Authors:  Harshal A Deshmukh; Helen M Colhoun; Toby Johnson; Paul M McKeigue; D John Betteridge; Paul N Durrington; John H Fuller; Shona Livingstone; Valentine Charlton-Menys; Andrew Neil; Neil Poulter; Peter Sever; Denis C Shields; Alice V Stanton; Aurobindo Chatterjee; Craig Hyde; Roberto A Calle; David A DeMicco; Stella Trompet; Iris Postmus; Ian Ford; J Wouter Jukema; Mark Caulfield; Graham A Hitman
Journal:  J Lipid Res       Date:  2012-02-24       Impact factor: 5.922

Review 7.  Human Genetics and the Causal Role of Lipoprotein(a) for Various Diseases.

Authors:  Florian Kronenberg
Journal:  Cardiovasc Drugs Ther       Date:  2016-02       Impact factor: 3.727

8.  Genome-Wide Association Study Highlights APOH as a Novel Locus for Lipoprotein(a) Levels-Brief Report.

Authors:  George Thanassoulis; James C Engert; Mary Hoekstra; Hao Yu Chen; Jian Rong; Line Dufresne; Jie Yao; Xiuqing Guo; Michael Y Tsai; Sotirios Tsimikas; Wendy S Post; Ramachandran S Vasan; Jerome I Rotter; Martin G Larson
Journal:  Arterioscler Thromb Vasc Biol       Date:  2020-10-29       Impact factor: 8.311

9.  Association between the DOCK7, PCSK9 and GALNT2 Gene Polymorphisms and Serum Lipid levels.

Authors:  Tao Guo; Rui-Xing Yin; Feng Huang; Li-Mei Yao; Wei-Xiong Lin; Shang-Ling Pan
Journal:  Sci Rep       Date:  2016-01-08       Impact factor: 4.379

10.  A genome-wide association meta-analysis on lipoprotein (a) concentrations adjusted for apolipoprotein (a) isoforms.

Authors:  Salome Mack; Stefan Coassin; Rico Rueedi; Noha A Yousri; Ilkka Seppälä; Christian Gieger; Sebastian Schönherr; Lukas Forer; Gertraud Erhart; Pedro Marques-Vidal; Janina S Ried; Gerard Waeber; Sven Bergmann; Doreen Dähnhardt; Andrea Stöckl; Olli T Raitakari; Mika Kähönen; Annette Peters; Thomas Meitinger; Konstantin Strauch; Ludmilla Kedenko; Bernhard Paulweber; Terho Lehtimäki; Steven C Hunt; Peter Vollenweider; Claudia Lamina; Florian Kronenberg
Journal:  J Lipid Res       Date:  2017-05-16       Impact factor: 5.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.